1Zogopoulous G, Rothenmund H, Eppel A, et al. The P239Spalladin variant does not account for a significant fraction of hereditary or early onset pancreas cancer. Hum Genet,2007,121:635 - 637.
2Kashino Y, Harayama T, Pakrasi HB, et al. Preparation of membrane proteins for analysis by two-dimensional gel electrophoresis. Chromatogr B,2007,849(2) :282 -292.
3Tong ER, Shaw J, Middleton B. Validation and development of fluorescence two-dimensional differential gel electrophoresis proteomics technology. Proteomies,2001,1 ( 3 ) :377 - 396.
4Gygi S P, Rist B, Gerber S A, et al. Quantitative analysis of complex protein mixtures using isotopecoded affinity tags. Nat Biotcchnol, 1999,17 (10) :994 - 999.
5Imamura T, Kanai F, Kawakami T, et al. Proteomic analysis of the TGF-beta signaling pathway in pancreatic carcinoma cells stable RNA interference to silence Smad 4 expression. Biochem Biophys Res Commun ,2004,318 ( 1 ) :289 - 296.
6Cecconi D, Donadelli M, Scarpa A, el al. Proteomic analysis of pancreatic ductal carcinoma cells after combined treatment with gemcitabine and trichostatin A. Proteome Res ,2005,4 : 1909 - 1916.
7Mikuriya K, Kuramitsu Y, Ryozawa S, et al. Expression of glyeolytic enzymes is increased in pancreatic cancerous tissues as evidenced by proteomie profiling by two - dimensional eleetrophoresis and liquid chromatography - mass spectrometry. Int J Oneol, 2007,30:847 - 855.
8Rosty C, Goggins M, Identification of differentially expressed proteins in pancreatic cancer using a global proteomic approach. Methods Mol Med,2005,103 : 189 - 19.
9Koopmann J, Rosenzweig CN, Zhang Z, et al. Serum markers in patients with resectable pancreatic adenocarcinoma: macrophage inhibitory cytokine 1 versus CA19-9. Clin Cancer Res,2006,12(2) :442 - 446.
10Bloomston M, Zhou JX, Rosemurgy AS, et al. Fibrinogen gamma overexpression in pancreatic cancer identified by large-scale proteomic analysis of serum samples. Cancer Res,2006,66 (5) :2592 - 2599.
5Lefrance D,Launay D,Dubucquoi S. Characterizaton of discriminant human btain antigets in neuropsychatric systemic lupus erythematosus using an immunoproteomic approach[J].Arthritis and Rheumatism,2007,(10):3420-3432.
6Sawai S,Umemura H,Mor M. Serum leavels of complement C4 fragments correlate with disease activity in multiple sclerosis:Proteomic analysis[J].Journal of Neuroimmunology,2010,(1/2):112-115.
7Pavon E,Munoz P. Proteomic analysis of plasma from patients with systemic lupus erythematosus:Increased presence of haptoglobin alpha2 polypeptde chains over the alphal isoforms[J].Proteomics,2006,(04):282-292.
8Amosy E,M'Koma MD,Erin H Seeley. Proteomic Profiling of Mucosal and Submucosal Colonic Tissues Yields Protein Signatures that Differentiate the Inflammatory Colitides[J].Inflammatory Bowel Diseases,2011,(04):875-883.
9May D,Pan S,Crispin DA. Investigating neoplastic progression of ulcerative colitis with label-free comparative proteomics[J].Journal of Proteome Research,2011,(01):200-209.doi:10.1021/pr100574p.
10Fogt F,Jian BO,Krieg RC. Proteomic analysis of mucosal preparations from patients with ulcerative colitis[J].Mol Med Reports,2008.51-54.
